Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible assets, net of amortization totaled $1.3 million and $1.4 million as of March 31, 2015 and December 31, 2014, respectively and consist of intellectual property purchased during the years ended December 31, 2014 and 2013. A portion of these assets, approximating $0.4 million, which represents software license agreements, was placed into service as of March 31, 2015. Amortization of intangible assets was $0.03 million for the three months ended March 31, 2015. There was no amortization recorded for the three months ended March 31, 2014. The terms of the some of these license agreements provide for use of the licensed software into perpetuity while others are more definite. The Company amortizes the cost of the license agreements over their estimated useful lives, which range from three to five years. The Company recorded an impairment charge of $0.1 million during the three months ended March 31, 2014 on one of the software licenses placed into service. The Company did not record any impairment charges related to intangible assets during the three months ended March 31, 2015. As of March 31, 2015, intangible assets not yet placed into service totaled approximately $1.1 million, and management anticipates these assets will be placed in service during the quarter ending June 30, 2015.

The following table illustrates the estimated future amortization expense of intangible assets as of March 31, 2015 (in thousands):



Fiscal Years	Estimated Amortization Expense
2016	$	139
2017	328
2018	280
2019	214
2020	214
Thereafter	161
Total	$	1,336

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details